Clinical pharmacy cardiac risk service for managing patients with coronary artery disease in a health maintenance organization
- 1 January 2007
- journal article
- Published by Oxford University Press (OUP) in American Journal of Health-System Pharmacy
- Vol. 64 (1) , 77-84
- https://doi.org/10.2146/ajhp060022
Abstract
Purpose. A clinical pharmacy service for managing the treatment of coronary artery disease in a health maintenance organization is described.Keywords
This publication has 20 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Treatment of Hypertension in Adults With DiabetesDiabetes Care, 2003
- Fish Consumption, Fish Oil, Omega-3 Fatty Acids, and Cardiovascular DiseaseCirculation, 2002
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Ineffective Secondary Prevention in Survivors of Cardiovascular Events in the US PopulationArchives of internal medicine (1960), 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol LevelsNew England Journal of Medicine, 1996
- Reducing Low-Density Lipoprotein Cholesterol Levels in an Ambulatory Care SystemArchives of internal medicine (1960), 1995
- Criteria of drug-induced liver disordersJournal of Hepatology, 1990